These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4040858)

  • 21. Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma.
    Neijt JP; ten Bokkel Huinink WW; van der Burg ME; van Oosterom AT; Vriesendorp R; Kooyman CD; van Lindert AC; Hamerlynck JV; van Lent M; van Houwelingen JC
    Lancet; 1984 Sep; 2(8403):594-600. PubMed ID: 6147640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy in recurrent epithelial ovarian cancer (EOC): an analysis of prognostic factors.
    Shamsunder S; Kumar L; Gupta S; Kumar S; Bhatla N; Singh R; Kochupillai V
    J Obstet Gynaecol Res; 2000 Jun; 26(3):215-22. PubMed ID: 10932985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supraventricular tachycardia. A probable complication of platinum treatment.
    Hashimi LA; Khalyl MF; Salem PA
    Oncology; 1984; 41(3):174-5. PubMed ID: 6539459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of combination chemotherapy of ovarian cancer: cyclophosphamide, adriamycin and cisplatin versus 5-fluorouracil, cyclophosphamide and mitomycin C.
    Sawada M; Yamasaki M; Urabe T; Ozaki M; Yanagita T; Takayama K; Taki I
    Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):315-21. PubMed ID: 2099727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness of 3-drug therapy in patients with advanced ovarian cancer].
    Kwaśniewska-Rokicińska C; Kaleta B; Kumor-Głodny T
    Ginekol Pol; 1989 Feb; 60(2):86-9. PubMed ID: 2680790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermittent intensive combination chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (cyclic PAC chemotherapy) for ovarian cancer.
    Inoue M; Nakanishi K; Ueda G; Tanizawa O
    Am J Clin Oncol; 1992 Feb; 15(1):1-6. PubMed ID: 1550076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polychemotherapy with carmustine, cyclophosphamide plus adriamycin in the treatment of advanced ovarian cancer.
    Facchini V; Gadducci A; Bogi G; Colombi L; Basile AG; Ballantini M; De Pasquale F; Fioretti P
    Eur J Gynaecol Oncol; 1985; 6(1):37-40. PubMed ID: 4038650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose cisplatin combination chemotherapy in the treatment of advanced epithelial ovarian carcinoma.
    Hainsworth JD; Burnett LS; Jones HW; Grosh WW; Johnson DH; Greco FA
    J Clin Oncol; 1990 Mar; 8(3):502-8. PubMed ID: 2407811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chemotherapy in advanced forms of carcinoma of the ovary].
    Calciati A; Clerico M; Donadio M; Giaccone G
    Minerva Ginecol; 1984 Apr; 36(4):195-8. PubMed ID: 6431334
    [No Abstract]   [Full Text] [Related]  

  • 30. A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer.
    Bruckner HW; Dinse GE; Davis TE; Falkson G; Creech RH; Arseneau JC; Greenspan EM; Brodovsky HS; Pagano M; Hahn RG
    Cancer; 1985 Jan; 55(1):26-40. PubMed ID: 3917352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term survival in ovarian cancer. Mature data from The Netherlands Joint Study Group for Ovarian Cancer.
    Neijt JP; ten Bokkel Huinink WW; van der Burg ME; van Oosterom AT; Willemse PH; Vermorken JB; van Lindert AC; Heintz AP; Aartsen E; van Lent M
    Eur J Cancer; 1991; 27(11):1367-72. PubMed ID: 1835850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinoma.
    Richman CM; Podczaski E; Weiser PA; Herbst AL
    Oncology; 1986; 43(1):12-7. PubMed ID: 3079898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring the cytotoxic potential of a sequential polychemotherapy (adriamycin/cisplatin-vincristine/cyclophosphamide-high dose methotrexate) in patients with advanced ovarian cancer with the tumor marker CA-125.
    Sevelda P; Dittrich C; Salzer H; Pateisky N; Spona J
    Cancer Detect Prev; 1986; 9(5-6):521-8. PubMed ID: 3465442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective sequential trials of induction weekly cisplatin followed by monthly cisplatin, doxorubicin, cyclophosphamide and paclitaxel and cisplatin in optimal (< or = 1 cm) stage III and IV ovarian cancer.
    Piver MS; Eltabbakh GH; Hempling RE; Recio FO; Blumenson LE
    Eur J Gynaecol Oncol; 1998; 19(1):5-10. PubMed ID: 9476049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cyclophosphamide, hexamethylmelamine, 5 fluorouracil (CHF) regimen in the treatment of advanced and recurrent ovarian cancer.
    Posada JG; Marantz AB; Yeung KY; Smith FP; Delgado G; Edwards BK; Schein PS
    Gynecol Oncol; 1985 Jan; 20(1):23-31. PubMed ID: 3917421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of cytoxan, adriamycin, and cis-platinum on cervical, vaginal cytology.
    Belinson JL; Jarrell M; McClure M; Papillo J; Korson R
    Gynecol Oncol; 1985 Jan; 20(1):78-82. PubMed ID: 4038391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclophosphamide, adriamycin and cisplatin (CAP) versus cyclophosphamide, adriamycin and vincristin (CAV) in the treatment of advanced ovarian cancer: a randomized study.
    Krommer CF; Szalai JP
    Ann Oncol; 1992 Jan; 3(1):37-9. PubMed ID: 1606067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of 2 different forms of chemotherapy on remission in patients with advanced ovarian cancer].
    Krommer K; Keller G; Csaba I; Garadnay B; Göcze P
    Zentralbl Gynakol; 1990; 112(17):1105-10. PubMed ID: 2264421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II trial of cyclophosphamide and adriamycin in refractory squamous cell carcinoma of the head and neck. An effective salvage regimen.
    Bitran JD; Goldman M
    Am J Clin Oncol; 1985 Feb; 8(1):61-4. PubMed ID: 2581437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schedule and dosage modification of a cyclophosphamide, hexamethylmelamine, doxorubicin, cisplatin combination chemotherapy regimen for refractory ovarian cancer.
    Bruckner HW; Cohen CJ; Bhardwaj S; Feuer E; Chesser MR; Holland JF
    Eur J Cancer Clin Oncol; 1989 Sep; 25(9):1273-9. PubMed ID: 2509207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.